Mannkind Corp (NASDAQ: MNKD) on Tuesday, plunged -0.18% from the previous trading day, before settling in for the closing price of $5.59. Within the past 52 weeks, MNKD’s price has moved between $3.38 and $7.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 37.70% over the last five years. The company achieved an average annual earnings per share of 357.14%. With a float of $266.59 million, this company’s outstanding shares have now reached $275.78 million.
The firm has a total of 414 workers. Let’s measure their productivity. In terms of profitability, gross margin is 71.91%, operating margin of 20.51%, and the pretax margin is 9.37%.
Mannkind Corp (MNKD) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mannkind Corp is 3.33%, while institutional ownership is 56.36%. The most recent insider transaction that took place on Nov 22 ’24, was worth 465,323. In this transaction Director of this company sold 67,536 shares at a rate of $6.89, taking the stock ownership to the 1,075,026 shares. Before that another transaction happened on Nov 22 ’24, when Company’s Director proposed sale 67,536 for $6.89, making the entire transaction worth $465,397.
Mannkind Corp (MNKD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 357.14% per share during the next fiscal year.
Mannkind Corp (NASDAQ: MNKD) Trading Performance Indicators
Mannkind Corp (MNKD) is currently performing well based on its current performance indicators. A quick ratio of 4.17 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.76. Likewise, its price to free cash flow for the trailing twelve months is 53.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.07, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Mannkind Corp (MNKD)
Analysing the last 5-days average volume posted by the [Mannkind Corp, MNKD], we can find that recorded value of 1.4 million was lower than the volume posted last year of 1.92 million. As of the previous 9 days, the stock’s Stochastic %D was 19.01%. Additionally, its Average True Range was 0.22.
During the past 100 days, Mannkind Corp’s (MNKD) raw stochastic average was set at 5.53%, which indicates a significant decrease from 15.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.51% in the past 14 days, which was lower than the 33.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.27, while its 200-day Moving Average is $5.84. Now, the first resistance to watch is $5.64. This is followed by the second major resistance level at $5.69. The third major resistance level sits at $5.76. If the price goes on to break the first support level at $5.52, it is likely to go to the next support level at $5.45. Should the price break the second support level, the third support level stands at $5.40.
Mannkind Corp (NASDAQ: MNKD) Key Stats
Market capitalization of the company is 1.54 billion based on 275,778K outstanding shares. Right now, sales total 198,960 K and income totals -11,940 K. The company made 70,080 K in profit during its latest quarter, and 11,550 K in sales during its previous quarter.
